Unlike, HNF1A and HNF4A monogenic diabetes, pancreatic atrophy is common in those with HNF1B mutations, therefore carriers do not display the same sensitivity to SU therapy and often require insulin therapy. The gene discussed is HNF1A; the disease is diabetes mellitus.